Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Tempest Therapeutics, Inc. | mlnd-20201231xex321.htm |
| EX-31.2 - EX-31.2 - Tempest Therapeutics, Inc. | mlnd-20201231xex312.htm |
| EX-31.1 - EX-31.1 - Tempest Therapeutics, Inc. | mlnd-20201231xex311.htm |
| EX-23.1 - EX-23.1 - Tempest Therapeutics, Inc. | mlnd-20201231xex231.htm |
| EX-10.32 - EX-10.32 - Tempest Therapeutics, Inc. | mlnd-20201231xex1032.htm |
| EX-10.31 - EX-10.31 - Tempest Therapeutics, Inc. | mlnd-20201231xex1031.htm |
| EX-10.30 - EX-10.30 - Tempest Therapeutics, Inc. | mlnd-20201231xex1030.htm |
| EX-10.29 - EX-10.29 - Tempest Therapeutics, Inc. | mlnd-20201231xex1029.htm |
| 10-K - 10-K - Tempest Therapeutics, Inc. | mlnd-20201231.htm |
Exhibit 21.1
| Name of Subsidiary | Jurisdiction of Organization | ||||
| Millendo Therapeutics SAS | France | ||||
| Millendo Therapeutics US, Inc. | Delaware | ||||
| Millendo Therapeutics Ltd | London, England | ||||
| OvaScience Securities Corporation | Massachusetts | ||||
| OvaScience Bermuda Limited | Hamilton, Bermuda | ||||
| Mars Merger Corp. | Delaware | ||||